Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,782.81
(
2.51%
)
US TECH 100
24,129.20
(
-0.47%
)
Dow Jones
47,909.92
(
2.85%
)
Brent Oil
95.77
(
0.98%
)
Bitcoin
71,354.05
(
0.31%
)
News Focus
News Focus
Post# of 257375
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

jbog

Send PM Follow Ignore
Followers 64
Posts 11874
Boards Moderated 0
Alias Born 07/16/2006

jbog

Re: DewDiligence post# 119170

Monday, 05/02/2011 8:33:16 AM

Monday, May 02, 2011 8:33:16 AM

Post# of 257375
Dew,

There's no question in my mind that Teva is trying to relieve the impact of generic Copaxone. As long as they continue with their decent free cash flow I think we'll see more deals or partnerships out of them.

Their OGXI partnership last year was a 1st for them, then they came along with the PG and now Cephalon deals.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today